Letermovir API Suppliers & Bulk Manufacturers
Available Forms: API (drug substance)
Available Strengths: USP grade or in-house specification
Reference Brands: Prevymis
Category: Active Pharmaceutical Ingredient
Letermovir is a CMV antiviral used in oral and intravenous transplant products. It is sourced by antiviral formulators, CDMOs and generic R&D teams preparing filings.
Manufacture or export Letermovir API? List it or send an offer →
Product Description:
Letermovir is an antiviral that inhibits the cytomegalovirus (CMV) DNA terminase complex, so the virus cannot package its DNA into new particles. It is approved for prophylaxis of CMV infection and disease in CMV-seropositive recipients of an allogeneic haematopoietic stem cell transplant, and for prophylaxis of CMV disease in high-risk kidney transplant recipients, in adults and in defined paediatric groups (reference brand: Prevymis).
Specification at a glance
| Traded form | Free base; single (S)-enantiomer of a dihydroquinazoline, very slightly soluble in water |
|---|---|
| CAS number | 917389-32-3 |
| Molecular formula | C29H28F4N4O4 |
| Molecular weight | 572.55 g/mol |
| Pharmacopoeia | No Ph. Eur., BP or JP monograph found. Letermovir was listed by USP for monograph development and its current USP status is unverified; otherwise supplied to an in-house specification. |
Regulatory files and timing
The FDA list of Drug Master Files (third quarter 2026) shows 10 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.
Generic or biosimilar entry. United States: Patent expiry; entry not confirmed (2029). European Union: Patent expiry; entry not confirmed (2029).
Handling and quality points
Letermovir has one stereocentre, so the specification should include chiral purity with a limit for the (R)-enantiomer. Its low water solubility means the solid form and particle size influence dissolution, so confirm whether the material is amorphous or crystalline and how it behaves under heat and humidity. If you plan an intravenous product, check that the supplier can meet endotoxin and bioburden limits suitable for parenteral use.
Send an API enquiry All specialty APIs
Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.
Letermovir API — third party manufacturing & bulk supply
Letermovir API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Letermovir API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Letermovir API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Letermovir API →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Most buyers ask for the GMP certificate, a US DMF letter of access or EU ASMF, a CoA with chiral purity and related substances, and stability data. A nitrosamine risk assessment and ICH M7 assessment for mutagenic impurities from the synthesis are standard requests. For injectable use, endotoxin and microbial data are needed as well.
Letermovir is a single (S)-enantiomer, and makers either resolve a racemic intermediate or use an asymmetric step. Ask for the chiral HPLC method, the enantiomer limit and data showing the configuration does not change during storage. The same method should be suitable for your release and stability testing.
Yes. We connect licensed formulation manufacturers, CDMOs and R&D teams with GMP-compliant letermovir producers, and we review their paperwork before any introduction. Your details stay with us until both sides agree to share them.
Related Products
Linaclotide API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Linzess, Constella
View DetailsDalbavancin Hydrochloride API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Dalvance, Xydalba
View DetailsPonatinib Hydrochloride API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Iclusig
View DetailsAbaloparatide API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Tymlos, Eladynos
View DetailsEpinephrine
Strength:
High-purity crystalline API, 98% purity (USP Standard)
Form: Crystalline powder
Reference Brands: EpiPen, Adrenalin (US)
View DetailsDisodium Phosphate
Strength:
excipient, buffering agent
Form: Granules/ Powder
Reference Brands:
View DetailsCholestyramine
Strength:
API Purity: 98% (on dry basis)/ Standard content expressed as Cholestyramine Resin equivalent
Form: Powder / Granules for Suspension
Reference Brands: Questran (US/EU)
View DetailsLiothyronine
Strength:
Purity 99.5% (on anhydrous basis EP,BP,USP standard)
Form: White to off-white crystalline powder
Reference Brands:
View DetailsUsually answered within 48 hours | GMP documents shared before you commit